Computed tomography-guided argon-helium cryoablation for sacrum chordoma
Authors:
Open Access
- 16 October 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (42) , e22604
Abstract
We examined the therapeutic effects of argon-helium cryoablation guided by computed tomography (CT) in the treatment of sacral chordoma. This is a retrospective study. CT-guided argon-helium cryoablation was used to treat 9 sacral chordoma patients at our centers between January 2016 and June 2019. We collected data on treatment response and success. Data from long-term follow-up of treatment outcomes were also assessed. All patients were treated successfully according to the indicated technical parameters. There were no reports of procedure-related complications from any of the patients. Complete response (CR) was also achieved in all patients. Six patients (66.7%) achieved initial CR after 1 treatment session and 3 patients (33.3%) achieved secondary CR after 2 treatment sessions. The chordoma-related symptoms improved significantly in all patients after treatment. The mean visual analogue scale score improved from 7.3 before treatment to 4.2 after treatment (P < .001). The mean function score improved from 3.2 before treatment to 1.4 after treatment (P < .001). The median length of follow-up for all patients was 33 months (range: 6–46 months). All patients were alive during the follow-up. Two (22.2%) patients experienced local recurrence (LR) at 6 and 9 months after treatment, respectively. These patients had revised treatment with trans-arterial embolism (n = 1) or repeat ablation (n = 1). The median progression-free survival was 36.8 months. Treatment of sacral chordoma with CT-guided argon-helium cryoablation is effective and offers a potentially beneficial therapeutic alternative for patients with the condition.Keywords
Funding Information
- Program of 2019 Xuzhou clinical technique research (2109GG002)
This publication has 10 references indexed in Scilit:
- Argon–helium cryoablation for liver carcinoma in high-risk locations: Safety and efficacyCryobiology, 2019
- Analysis of therapeutic effectiveness and prognostic factor on argon-helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinomaJournal of Cancer Research and Therapeutics, 2016
- Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan CriteriaPLOS ONE, 2015
- Computed tomography imaging-guided percutaneous argon–helium cryoablation of muscle-invasive bladder cancer: Initial experience in 32 patientsCryobiology, 2014
- Management of Liver Cancer Argon-helium Knife Therapy with Functional Computer Tomography Perfusion ImagingTechnology in Cancer Research & Treatment, 2014
- Occlusion of the abdominal aorta by balloon dilation catheter assisting surgical excision of a sacrum chordoma: case report.2009
- Surgical Management of Petroclival Chordomas: Report of Eight CasesJournal of Neurological Surgery Part B: Skull Base, 2006
- Surgical Excision of Sacral Tumors Assisted by Occluding the Abdominal Aorta with a Balloon Dilation Catheter: A Report of 3 CasesSpine, 2005
- Operative Management of Sacral ChordomaJournal of Bone and Joint Surgery, 2005
- Percutaneous Radiofrequency Ablation of ChordomaAmerican Journal of Roentgenology, 2004